Assembly Biosciences, Inc. (ASMB)

Assembly Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	22.53	38.34	19.84	52.42	45.63	59.44
Short-Term Investments	210.02	73.74	110.41	39.19	101	156.97
Cash & Short-Term Investments	232.56	112.08	130.25	91.61	146.63	216.41
Cash Growth	144.91%	-13.95%	42.18%	-37.52%	-32.25%	-21.03%
Accounts Receivable	0.91	-	0.04	0.94	0.34	1.23
Other Receivables	1	0.4	0.3	0.3	-	-
Receivables	1.91	0.4	0.34	1.24	0.34	1.23
Prepaid Expenses	2.34	3.02	3.2	4.11	7.24	6.85
Total Current Assets	236.81	115.5	133.79	96.97	154.2	224.49
Property, Plant & Equipment	2.87	3.35	2.72	3.94	7.18	10.73
Long-Term Investments	-	-	-	-	27.97	-
Goodwill	-	-	-	-	-	12.64
Other Intangible Assets	-	-	-	-	-	29
Long-Term Deferred Charges	-	-	-	0.2	0.2	0.8
Other Long-Term Assets	0.31	0.31	0.31	0.69	1.5	5.59
Total Assets	240	119.17	136.82	101.79	191.06	283.25
Accounts Payable	1.68	0.59	0.46	2.49	2.66	4.6
Accrued Expenses	8.79	9.14	6.63	9.84	10.26	12.27
Current Portion of Leases	0.55	0.46	1.22	3.36	3.15	3.4
Current Unearned Revenue	42.36	37.62	30.92	-	-	-
Other Current Liabilities	-	-	-	0.6	-	4.16
Total Current Liabilities	53.38	47.8	39.23	16.3	16.07	24.43
Long-Term Leases	2.21	2.63	1.12	0.1	3.33	6.73
Long-Term Unearned Revenue	1.72	35.38	55.38	2.73	2.73	8.99
Long-Term Deferred Tax Liabilities	-	-	-	-	-	2.53
Total Liabilities	57.3	85.81	95.73	19.13	22.13	42.68
Common Stock	0.02	0.01	0.01	0	0.05	0.03
Additional Paid-In Capital	1,037	859.49	826.92	807.98	800.73	742.39
Retained Earnings	-854.14	-825.93	-785.75	-724.52	-631.43	-501.57
Comprehensive Income & Other	-0.09	-0.21	-0.08	-0.8	-0.42	-0.27
Shareholders' Equity	182.7	33.36	41.1	82.66	168.93	240.58
Total Liabilities & Equity	240	119.17	136.82	101.79	191.06	283.25
Total Debt	2.76	3.09	2.34	3.47	6.48	10.13
Net Cash (Debt)	229.8	108.99	127.91	88.15	168.12	206.28
Net Cash Growth	145.75%	-14.79%	45.11%	-47.57%	-18.50%	-21.20%
Net Cash Per Share	26.69	18.15	27.94	21.85	46.61	69.87
Filing Date Shares Outstanding	15.82	7.5	5.48	4.33	4.01	3.19
Total Common Shares Outstanding	15.82	7.46	5.48	4.07	4.01	2.84
Working Capital	183.43	67.7	94.56	80.67	138.13	200.06
Book Value Per Share	11.55	4.47	7.50	20.29	42.13	84.84
Tangible Book Value	182.7	33.36	41.1	82.66	168.93	198.94
Tangible Book Value Per Share	11.55	4.47	7.50	20.29	42.13	70.16
Machinery	-	-	-	0.8	0.72	0.95
Leasehold Improvements	-	-	-	1.63	1.63	2.49

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q